{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T04:42:10Z","timestamp":1759898530974,"version":"build-2065373602"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Background and purpose<\/jats:title><jats:p>Radiation-induced hippocampal damage poses a risk of cognitive decline following radiotherapy. Existing international guidelines for nasopharyngeal carcinoma (NPC) radiotherapy provide insufficient specific guidance on hippocampus sparing, which is critically needed, particularly for patients with locally advanced disease. This study was conducted to retrospectively evaluate the dosimetric feasibility and safety of a hippocampus-sparing VMAT technique for locally advanced NPC. Specifically, we assessed its ability to reduce hippocampal dose while ensuring target coverage and respecting dose limits for other organs at risk based on a comparative analysis of treatment plans.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and methods<\/jats:title><jats:p>This retrospective study included the clinical data and treatment plans of 60 patients previously treated for locally advanced nasopharyngeal carcinoma. For all patients, target volumes and organs at risk (OARs) had been delineated according to international guidelines. Notably, for the purpose of this analysis, the left and right hippocampi were meticulously delineated as independent OARs. For this dosimetric comparison, the cohort was divided into two groups: the conventional group (n=30), consisting of patients treated with a conventional VMAT plan, and the hippocampus-sparing group (n=30), for whom HS-VMAT plans were retrospectively analyzed or generated. A systematic comparative analysis of dosimetric and biological data was subsequently conducted between the two groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Consistent with previous studies, hippocampus-sparing plans showed statistically significant differences from conventional VMAT plans in multiple parameters, resulting in significantly reduced radiation doses to both the left and right hippocampi. For instance, left hippocampal Dmax was 35.40 Gy compared to 51.15 Gy in conventional plans (a decrease of 15.75 Gy), and right hippocampal Dmax was 36.47 Gy compared to 47.27 Gy (a decrease of 10.8 Gy). Similar significant reductions were observed for Dmean (left: 11.69 Gy vs 16.52 Gy; right: 11.79 Gy vs 16.00 Gy) and D40% (left: 11.38 \u00b1 6.76 Gy vs 16.42 \u00b1 6.99 Gy; right: 11.50 Gy vs 16.62 Gy). However, the Dmin for the left and right hippocampi did not show a significant decrease. Additionally, slight differences in target homogeneity were noted. EUD and NTCP analyses from both groups further demonstrated that reducing hippocampal dose with the hippocampus-sparing plan effectively lowered the predicted probability of complications in the left and right hippocampal tissue.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This retrospective dosimetric comparison demonstrates the feasibility of the hippocampus-sparing technique in patients with locally advanced nasopharmenyngeal carcinoma. Our analysis indicates that HS-VMAT plans can achieve significant reductions in key hippocampal dose parameters, such as Dmax, Dmean, and D40%, while simultaneously maintaining adequate target coverage and adhering to dose constraints for other organs at risk. Supported by both dosimetric and biological (NTCP) analyses, these findings suggest a significantly lower predicted probability of hippocampus-related complications with the HS-VMAT approach. Therefore, our results support HS-VMAT as a theoretically feasible and clinically valuable strategy, with potential significance for preserving the neurocognitive function of patients with locally advanced NPC.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2025.1628590","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T04:18:32Z","timestamp":1759897112000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of hippocampus-sparing VMAT versus conventional VMAT in locally advanced nasopharyngeal carcinoma: a dosimetric and biological analysis"],"prefix":"10.3389","volume":"15","author":[{"given":"Zhi Wei","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhang Rui","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei Wei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Song Huan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.12.007","article-title":"Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"32","author":"Bossi","year":"2021","journal-title":"Ann Oncol off J Eur Soc Med Oncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.03237","article-title":"Chemotherapy in combination with radiotherapy for definitive-intent treatment of stage II-IVA nasopharyngeal carcinoma: CSCO and ASCO guideline","volume":"39","author":"Chen","year":"2021","journal-title":"J Clin Oncol off J Am Soc Clin Oncol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"178","DOI":"10.4103\/jrcr.jrcr_56_20","article-title":"Dosimetric evaluation of hippocampus incidental radiation dose in nasopharyngeal cancer patients treated with intensity-modulated radiotherapy","volume":"11","author":"Jacob","year":"2020","journal-title":"J Radiat Cancer Res"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20130474","article-title":"Evaluation of hippocampus dose for patients undergoing intensity-modulated radiotherapy for nasopharyngeal carcinoma","volume":"87","author":"Khodayari","year":"2014","journal-title":"Br J Radiol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"5595","DOI":"10.1038\/s41598-018-23127-6","article-title":"Results of the radiation dose of head, body and tail of hippocampus in nasopharyngeal carcinoma patients treated with intensity modulated radiotherapy","volume":"8","author":"Zong-wen","year":"2018","journal-title":"Sci Rep"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.21037\/qims.2018.10.09","article-title":"Radiation-induced gray matter atrophy in patients with nasopharyngeal carcinoma after intensity modulated radiotherapy: a MRI magnetic resonance imaging voxel-based morphometry study","volume":"8","author":"Shi","year":"2018","journal-title":"Quant Imaging Med Surg"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.02767","article-title":"Hippocampal avoidance during whole-brain radiotherapy plus memantine for patients with brain metastases: phase III trial NRG oncology CC001","volume":"38","author":"Brown","year":"2020","journal-title":"J Clin Oncol off J Am Soc Clin Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noaa076","article-title":"Hippocampal radiotherapy dose constraints for predicting long-term neurocognitive outcomes: mature data from a prospective trial in young patients with brain tumors","volume":"22","author":"Goda","year":"2020","journal-title":"Neuro-Oncol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/s13014-015-0562-x","article-title":"Hippocampal dosimetry correlates with the change in neurocognitive function after hippocampal sparing during whole brain radiotherapy: a prospective study","volume":"10","author":"Tsai","year":"2015","journal-title":"Radiat Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(89)90462-8","article-title":"Optimization of radiation therapy, IV: A dose-volume histogram reduction algorithm [J","volume":"17","author":"Lyman","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmp.2007.07.001","article-title":"A free program for calculating EUD-based NTCP and TCP in external beam radiotherapy","volume":"23","author":"Gay","year":"2007","journal-title":"Phys Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2012.11.031","article-title":"Hippocampal dosimetry predicts neurocognitive function impairment after fractionated stereotactic radiotherapy for benign or low-grade adult brain tumors","volume":"85","author":"Gondi","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/pro6.1240","article-title":"A new formula for calculating normal tissue complication probability","volume":"8","author":"Cao","year":"2024","journal-title":"Precis Radiat Oncol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"16","DOI":"10.4103\/jmp.JMP_85_17","article-title":"Comparison of volumetric modulated arc therapy and intensity modulated radiation therapy for whole brain hippocampal sparing treatment plans based on radiobiological modeling","volume":"43","author":"Kendall","year":"2018","journal-title":"J Med Phys"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctro.2024.100751","article-title":"Comparison of conventional and hippocampus-sparing radiotherapy in nasopharyngeal carcinoma: In silico study and systematic review","volume":"46","author":"Peternel","year":"2024","journal-title":"Clin Transl Radiat Oncol"},{"key":"B16","article-title":"Celecoxib combined with hippocampus sparing intensity-modulated radiation therapy reduces the injury of cognitive function induced by radiotherapy in patients with nasopharyngeal carcinoma","author":"Fan","year":"2017","journal-title":"Int J Clin and E Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.57.2909","article-title":"Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trial","volume":"32","author":"Gondi","year":"2014","journal-title":"J Clin Oncol off J Am Soc Clin Oncol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noaa193","article-title":"Hippocampal avoidance whole-brain radiotherapy without memantine in preserving neurocognitive function for brain metastases: a phase II blinded randomized trial","volume":"23","author":"Yang","year":"2021","journal-title":"Neuro Oncol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.adro.2021.100681","article-title":"The hippocampus: A new organ at risk for postoperative radiation therapy for bucco-alveolar cancer? A dosimetric and biological analysis","volume":"6","author":"Nangia","year":"2021","journal-title":"Adv Radiat Oncol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.00639","article-title":"Randomized phase III trial of prophylactic cranial irradiation with or without hippocampal avoidance for small-cell lung cancer (PREMER): A GICORGOECP-SEOR study","volume":"39","author":"Rodr\u00edguez De Dios","year":"2021","journal-title":"J Clin Oncol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"3443","DOI":"10.1038\/s41598-017-03517-y","article-title":"The Hippocampus sparing volume modulated arc therapy does not influence plan quality on locally advanced nasopharyngeal carcinoma patients","volume":"7","author":"Gu","year":"2017","journal-title":"Sci Rep"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e0120141","DOI":"10.1371\/journal.pone.0120141","article-title":"Brain-sparing methods for IMRT of head and neck cancer","volume":"10","author":"Dunlop","year":"2015","journal-title":"PloS One"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e90007","DOI":"10.1371\/journal.pone.0090007","article-title":"Evaluation of the dosimetric feasibility of hippocampal sparing intensity-modulated radiotherapy in patients with locally advanced nasopharyngeal carcinoma","volume":"9","author":"Han","year":"2014","journal-title":"PloS One"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1177\/15330338211034269","article-title":"Effect of hippocampal avoidance using intensity modulated radiation therapy on cognitive performance in nasopharyngeal carcinoma patients","volume":"20","author":"Shen","year":"2020","journal-title":"Chin J Cancer Prev Treat"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-2903","article-title":"Molecular pathways: radiation-induced cognitive impairment","volume":"19","author":"Greene-Schloesser","year":"2013","journal-title":"Clin Cancer Res"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-024-01592-9","article-title":"Proton therapy in the treatment of head and neck cancers- review","volume":"26","author":"Ba\u0142a","year":"2024","journal-title":"Curr Oncol Rep"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2009.02.091","article-title":"Radiation dose-volume effects in the brain","volume":"76","author":"Lawrence","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16112085","article-title":"Current status and future directions of proton therapy for head and neck carcinoma","volume":"16","author":"Lillo","year":"2024","journal-title":"Cancers (Basel)"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1628590\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T04:18:33Z","timestamp":1759897113000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1628590\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,8]]},"references-count":28,"alternative-id":["10.3389\/fonc.2025.1628590"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1628590","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,8]]},"article-number":"1628590"}}